Synopsys (SNPS) shares closed more than 4% higher on Thursday, July 3 following the White House’s decision to lift ...

A large-scale Mendelian randomization study found no genetic evidence that vitamins A, C, or D reduce the risk of major ...

Synopsys is set for a faster rebound due to China sales resuming, an $8B backlog, and strong AI-driven tool demand. Click ...

In the latest trading session, Synopsys (SNPS) closed at $536.52, marking a -2.23% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.79%. Elsewhere, the Dow ...

Synopsys Inc. closed 11.73% below its 52-week high of $624.80, which the company reached on July 11th.

The stock's fall snapped a nine-day winning streak.

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

Human genotyping has never been hotter, and a sophisticated set of array-based tools now simplifies the process dramatically, facilitating everything from small basic research studies to complex ...

U.S. stock futures are little changed ahead of today's shortened trading session as investors await June jobs data and ...